{
    "organizations": [],
    "uuid": "a8c74ccb01ba5044fbc8ea1e0b73ff5369b3348c",
    "author": "",
    "url": "https://www.reuters.com/article/brief-corvus-pharmaceuticals-announces-i/brief-corvus-pharmaceuticals-announces-initiation-of-phase-1-1b-clinical-trial-of-cpi-006-in-patients-with-advanced-cancer-idUSASC09XRB",
    "ord_in_thread": 0,
    "title": "BRIEF-Corvus Pharmaceuticals Announces Initiation Of Phase 1/1B Clinical Trial Of CPI-006 In Patients With Advanced Cancer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 26 (Reuters) - Corvus Pharmaceuticals Inc:\n* CORVUS PHARMACEUTICALS ANNOUNCES INITIATION OF PHASE 1/1B CLINICAL TRIAL OF INVESTIGATIONAL ANTI-CD73 ANTIBODY, CPI-006, IN PATIENTS WITH ADVANCED CANCER Source text for Eikon:\n ",
    "published": "2018-04-26T15:55:00.000+03:00",
    "crawled": "2018-04-26T16:12:54.031+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "corvus",
        "pharmaceutical",
        "inc",
        "corvus",
        "pharmaceutical",
        "announces",
        "initiation",
        "phase",
        "clinical",
        "trial",
        "investigational",
        "antibody",
        "patient",
        "advanced",
        "cancer",
        "source",
        "text",
        "eikon"
    ]
}